CMB International
招银国际
CMB International is the investment arm of China Merchants Bank, active in Chinese venture capital as both a lead and follow-on investor across biotech, healthcare, and deep-tech sectors. Per the record, it has led a Series A in Yinjia Bio and joined rounds for companies including METiS Pharmaceuticals , Enhe Biotechnology , CytoNiche , and Zhuiyi , often co-investing alongside Sequoia China, 5Y Capital, and Lightspeed China. Its activity clusters in 2021–2025, with a concentration in life sciences and synthetic biology. elsewhere's corpus does not cover its fund size, founding date, or broader strategy beyond these deal participations.
AI-generated — may contain errors, please verify.
Coverage
Yunqi Capital Invests in Sunseeker's Series B, Accelerating Growth in Outdoor Robotics | Yunqi Capital
Full-Stack In-House R&D, Pioneering a New Future for Outdoor Intelligence
Haivivi Closes 200 Million Yuan Series A Round, Set to Launch Industry's First End-to-End AI Toy | BlueRun Portfolio
Bring Toys to Life
Zhongke Hydrogen Energy Closes Eight-Figure Pre-A Round, Accelerating Mass Production of Alkaline Hydrogen Production Composite Membranes
Focused on the mass production progress of separators and electrode products.
China Energy Storage (Zhongchu Guoneng) Completes 320 Million Yuan Pre-A+ Round to Accelerate New Energy Storage Technology Layout
A pioneer and leader in China's compressed air energy storage sector.
A grain of sand for the era, a mountain for USD funds
To survive in an era of sweeping change, keeping your eyes on the ground is never enough — you have to look up at the sky too.
7 Companies Raised Nearly 1.5 Billion Yuan, 4 Valued Above 1 Billion Yuan | FreeS Family Funding News · September
Every step of growth for an innovative company: from 0 to 1, from 1 to 10, and from 10 to 100
